The National Lipid Association (NLA) is an American non-profit multidisciplinary medical society that aims to enhance the practice of lipid management in clinical medicine. The NLA focuses on the prevention of cardiovascular disease and other lipid-related disorders."Saseen Co-Authors National Lipid Association Official Scientific Statement on Statin Intolerance". news.cuanschutz.edu. Retrieved 9 January 2023.
Overview
The National Lipid Association was formed in 1997 and has over 2,000 members."Who We Are". lipid.org. Retrieved 9 January 2023."USA – National Lipid Association (NLA)". athero.org. Retrieved 9 January 2023. It provides medical education for healthcare professionals and physicians to advance knowledge and certification in clinical lipidology. Joseph Saseen is the current president of NLA."The NLA Welcomes New Leadership". lipid.org. Retrieved 9 January 2023."Professor Joseph Saseen named president of National Lipid Association". news.cuanschutz.edu. Retrieved 9 January 2023. In 2014, the NLA proposed a working definition of statin intolerance and made general recommendations for health professionals."The National Lipid Association Addresses the Safety of Statins and Provides Recommendations to Clinicians and Patients". businesswire.com. Retrieved 9 January 2023.
The NLA have stated that by 2012, a wealth of evidence including numerous clinical trials examined by the Cholesterol Treatment Trialists' Collaboration has confirmed the lipid hypothesis."The Lipid Hypothesis". lipid.org. Retrieved 22 January 2024.
The NLA publishes the Journal of Clinical Lipidology."Journal of Clinical Lipidology". sciencedirect.com. Retrieved 9 January 2023.
Scientific statements
In 2019, the NLA's Nutrition and Lifestyle Task Force published a scientific statement based on a comprehensive review of recent clinical evidence on the effects of low and very-low-carbohydrate diets on the management of body weight and other cardiometabolic risk factors."Low-carbohydrate diet claims scrutinized". quackwatch.org. Retrieved 9 January 2023. The statement concluded that low and very-low-carbohydrate die are not superior to other dietary approaches for weight loss and are difficult to maintain in the long term.
In 2021, the NLA published a scientific statement on lipid measurements in the management of cardiovascular diseases."Utilization of Clinical Testing in the Setting of Dyslipidemia". acc.org. Retrieved 9 January 2023.
In 2022, the NLA published a scientific statement on statin intolerance, updating the definition which now classifies statin intolerance as either partial or complete."NLA 2022 Definition of Statin Intolerance". acc.org. Retrieved 9 January 2023. The 2022 statement recommends different strategies to help patients stay on statin medications, and alternative medications to those who cannot tolerate statins.. medscape.com. Retrieved 9 January 2023.
Selected publications
References
External links National Lipid Association